Larvol Delta - Blue-Earth-Therapeutics-initiates-Phase-2-Clinical-Trial-evaluating-the-efcacy-and-safety-of-Lutetium-177Lu-rhPSMA101-Injection-in-metastatic-castrate-resistant-prostate-cancer

177Lu-rhPSMA-10.1 - Bracco

https://www.prnewswire.com/news-releases/blue-earth-therapeutics-initiates-phase-2-clinical-trial-evaluating-the-efficacy-and-safety-of-lutetium-177lu-rhpsma-10-1-injection-in-metastatic-castrate-resistant-prostate-cancer-302441668.html

May 1, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next